Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Chronic Obstructive Lung Disease | Research

Proportions and risk factors of chronic obstructive pulmonary disease and preserved ratio impaired spirometry, and association with small airway disease, in the positive screening older population from China: a cross-sectional study

Authors: Le Sang, Xia Gong, Yunlei Huang, Jian Sun

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Early diagnosing Chronic Obstructive Pulmonary Disease (COPD) is relatively difficult. Therefore, the concepts of preserved ratio impaired spirometry (PRISm) and small airway disease (SAD) were proposed to achieve early diagnosis for COPD. Besides, the occurrence of COPD is positively related to age. However, the relationship among COPD, PRISm, and SAD still requires clarification. Thus, we estimated the proportions and risk factors of COPD and PRISm in the positive screening participants, and searched the methods of early diagnosing COPD via the SAD indicators.

Methods

A total of 53,641 residents aged more than 60 years old from Shaoxing City, Zhejiang Province, China, completed a series of screening projects. And 2327 of positive screening participants ultimately finished bronchodilator tests. The data were statistically analyzed to figure out the proportions and risk factors of COPD and PRISm, and the efficacy of early diagnosing COPD by the SAD indicators.

Results

Totally 2229 positive screening participants were included, the proportion of PRISm was 6.3% (141/2229), and of COPD was 78.2% (1743/2229). Statistical analyses showed that COPD patients were more likely to be smokers, males, and older. And COPD patients had higher questionnaire scores, meaning that they were more prone to have family history of respiratory diseases and more severe respiratory symptoms. Additionally, COPD patients had lower maximal mid-expiratory flow (MMEF) pred, forced expiratory flow (FEF) 75pred, and FEF50pred. And we found that male sex and presence of respiratory symptoms might lead to COPD and PRISm. Also, the methods of early diagnosing COPD through the SAD indicators might be acceptable.

Conclusion

There is a close association between COPD and decreased small airway function (SAF) among the participants included. Age, smoking, male sex, worse SAF, and respiratory symptoms might cause the progressing from normal people to PRISm, then to COPD patients. Besides, the SAD indicators such as MMEFpred, FEF75pred, and FEF50pred were included in lung function tests and bronchodilator tests. Intriguingly, it was found that early diagnosing COPD via the SAD indicators might be feasible. In the future, early diagnosis for COPD requires further research.
Literature
1.
go back to reference Global burden. Of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef Global burden. Of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.CrossRef
2.
go back to reference Yin P, Wu J, Wang L, Luo C, Ouyang L, Tang X et al. The Burden of COPD in China and its provinces: findings from the global burden of Disease Study 2019. Front Public Health. 2022;10(859499). Yin P, Wu J, Wang L, Luo C, Ouyang L, Tang X et al. The Burden of COPD in China and its provinces: findings from the global burden of Disease Study 2019. Front Public Health. 2022;10(859499).
4.
go back to reference Celli BR, Agustí A. COPD: time to improve its taxonomy? ERJ Open Res. 2018;4(1). Celli BR, Agustí A. COPD: time to improve its taxonomy? ERJ Open Res. 2018;4(1).
5.
go back to reference Halpin D, Criner G, Papi A, Singh D, Anzueto A, Martinez F, et al. Global Initiative for the diagnosis, management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1):24–36.CrossRefPubMedPubMedCentral Halpin D, Criner G, Papi A, Singh D, Anzueto A, Martinez F, et al. Global Initiative for the diagnosis, management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1):24–36.CrossRefPubMedPubMedCentral
6.
go back to reference Cosio B, Casanova C, Soler-Cataluna J, Soriano J, Garcia-Rio F, de Lucas P et al. Unravelling young COPD and pre-COPD in the general population. ERJ Open Res. 2023;9(1). Cosio B, Casanova C, Soler-Cataluna J, Soriano J, Garcia-Rio F, de Lucas P et al. Unravelling young COPD and pre-COPD in the general population. ERJ Open Res. 2023;9(1).
7.
go back to reference Wan E, Fortis S, Regan E, Hokanson J, Han M, Casaburi R, et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene Study. Am J Respir Crit Care Med. 2018;198(11):1397–405.CrossRefPubMedPubMedCentral Wan E, Fortis S, Regan E, Hokanson J, Han M, Casaburi R, et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene Study. Am J Respir Crit Care Med. 2018;198(11):1397–405.CrossRefPubMedPubMedCentral
8.
go back to reference Wijnant S, De Roos E, Kavousi M, Stricker B, Terzikhan N, Lahousse L et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55(1). Wijnant S, De Roos E, Kavousi M, Stricker B, Terzikhan N, Lahousse L et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020;55(1).
9.
go back to reference Kiani F, Ahmadi A. Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Sci Rep. 2021;11(1):1548.ADSCrossRefPubMedPubMedCentral Kiani F, Ahmadi A. Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Sci Rep. 2021;11(1):1548.ADSCrossRefPubMedPubMedCentral
10.
go back to reference Kim J, Lee C, Lee H, Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean National Health and Nutrition Examination Survey IV-VI. Respiration. 2022;101(1):25–33.CrossRefPubMed Kim J, Lee C, Lee H, Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean National Health and Nutrition Examination Survey IV-VI. Respiration. 2022;101(1):25–33.CrossRefPubMed
11.
go back to reference Weibel E. Lung morphometry: the link between structure and function. Cell Tissue Res. 2017;367(3):413–26.CrossRefPubMed Weibel E. Lung morphometry: the link between structure and function. Cell Tissue Res. 2017;367(3):413–26.CrossRefPubMed
12.
go back to reference O’Beirne S, Shenoy S, Salit J, Strulovici-Barel Y, Kaner R, Visvanathan S, et al. Ambient Pollution-related reprogramming of the human small Airway Epithelial Transcriptome. Am J Respir Crit Care Med. 2018;198(11):1413–22.CrossRefPubMedPubMedCentral O’Beirne S, Shenoy S, Salit J, Strulovici-Barel Y, Kaner R, Visvanathan S, et al. Ambient Pollution-related reprogramming of the human small Airway Epithelial Transcriptome. Am J Respir Crit Care Med. 2018;198(11):1413–22.CrossRefPubMedPubMedCentral
13.
go back to reference Xiao D, Chen Z, Wu S, Huang K, Xu J, Yang L, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. Lancet Respir Med. 2020;8(11):1081–93.CrossRefPubMed Xiao D, Chen Z, Wu S, Huang K, Xu J, Yang L, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. Lancet Respir Med. 2020;8(11):1081–93.CrossRefPubMed
14.
go back to reference Young AL, Bragman FJS, Rangelov B, Han MKGC, Lynch DA, Hawkes DJ, et al. Disease Progression modeling in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020;201(3):294–302.CrossRefPubMedPubMedCentral Young AL, Bragman FJS, Rangelov B, Han MKGC, Lynch DA, Hawkes DJ, et al. Disease Progression modeling in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020;201(3):294–302.CrossRefPubMedPubMedCentral
16.
go back to reference Yin X, Zheng Z, Dong Y, Li J, Yang S, Xu Q, et al. Comparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District. Front Public Health. 2023;11:1102509.CrossRefPubMedPubMedCentral Yin X, Zheng Z, Dong Y, Li J, Yang S, Xu Q, et al. Comparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District. Front Public Health. 2023;11:1102509.CrossRefPubMedPubMedCentral
17.
go back to reference Stafyla E, Kotsiou OS, Deskata K, Gourgoulianis K. Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist. Int J Chronic Obstr Pulm Dis. 2018;13:487–98.CrossRef Stafyla E, Kotsiou OS, Deskata K, Gourgoulianis K. Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist. Int J Chronic Obstr Pulm Dis. 2018;13:487–98.CrossRef
18.
go back to reference Mingzhi j, Jie C, Tingting J, 绍兴市城乡居民吸烟行为及影响因素分析. Shanghai J Prev Med. 2023;35(5):459–65. Mingzhi j, Jie C, Tingting J, 绍兴市城乡居民吸烟行为及影响因素分析. Shanghai J Prev Med. 2023;35(5):459–65.
19.
go back to reference Soleimanifar N, Assadiasl S, Kalateh E, Sadegh Hassanvand M, Sadr M, Mojtahedi H, et al. Circulating exosomes and Ambient Air Pollution exposure in COPD. Chronic Obstr Pulmonary Diseases: J COPD Foundation. 2023;10(4):412–21.CrossRef Soleimanifar N, Assadiasl S, Kalateh E, Sadegh Hassanvand M, Sadr M, Mojtahedi H, et al. Circulating exosomes and Ambient Air Pollution exposure in COPD. Chronic Obstr Pulmonary Diseases: J COPD Foundation. 2023;10(4):412–21.CrossRef
20.
go back to reference Johnson KM, Tan WC, Bourbeau J, Sin DD, Sadatsafavi M. The diagnostic performance of patient symptoms in screening for COPD. Respir Res. 2018;19(1). Johnson KM, Tan WC, Bourbeau J, Sin DD, Sadatsafavi M. The diagnostic performance of patient symptoms in screening for COPD. Respir Res. 2018;19(1).
21.
go back to reference Putcha N, Drummond MB, Connett JE, Scanlon PD, Tashkin DP, Hansel NN, et al. Chronic productive cough is Associated with death in smokers with early COPD. COPD: J Chronic Obstr Pulmonary Disease. 2013;11(4):451–8.CrossRef Putcha N, Drummond MB, Connett JE, Scanlon PD, Tashkin DP, Hansel NN, et al. Chronic productive cough is Associated with death in smokers with early COPD. COPD: J Chronic Obstr Pulmonary Disease. 2013;11(4):451–8.CrossRef
22.
go back to reference Dahne J, Player MS, Strange C, Carpenter MJ, Ford DW, King K, et al. Proactive electronic visits for Smoking Cessation and Chronic Obstructive Pulmonary Disease Screening in Primary Care: Randomized Controlled Trial of Feasibility, Acceptability, and Efficacy. J Med Internet Res. 2022;24(8):e38663.CrossRefPubMedPubMedCentral Dahne J, Player MS, Strange C, Carpenter MJ, Ford DW, King K, et al. Proactive electronic visits for Smoking Cessation and Chronic Obstructive Pulmonary Disease Screening in Primary Care: Randomized Controlled Trial of Feasibility, Acceptability, and Efficacy. J Med Internet Res. 2022;24(8):e38663.CrossRefPubMedPubMedCentral
Metadata
Title
Proportions and risk factors of chronic obstructive pulmonary disease and preserved ratio impaired spirometry, and association with small airway disease, in the positive screening older population from China: a cross-sectional study
Authors
Le Sang
Xia Gong
Yunlei Huang
Jian Sun
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02920-2

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.